| Identification | Back Directory | [Name]
Benzenesulfonamide,5-[[5-fluoro-4--[[4-(2-propyn-1-yloxy)phenyl]amino]-2-pyrimidinyl]amino]-2-methyl- | [CAS]
916741-98-5 | [Synonyms]
JAK-IN-10
5-((5-fluoro-4-((4-(prop-2-yn-1-yloxy)phenyl)amino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide
Benzenesulfonamide,5-[[5-fluoro-4--[[4-(2-propyn-1-yloxy)phenyl]amino]-2-pyrimidinyl]amino]-2-methyl- | [Molecular Formula]
C20H18FN5O3S | [MDL Number]
MFCD31544411 | [MOL File]
916741-98-5.mol | [Molecular Weight]
427.452 |
| Hazard Information | Back Directory | [Description]
JAK-IN-10 is a useful composition for treating and/or preventing dry eye disorders.
| [Uses]
JAK-IN-10 is a JAK inhibitor. JAK-IN-10 can be used for the research of dry eye disorders[1]. JAK-IN-10 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. | [IC 50]
JAK | [References]
[1]. Hong Ren,et al. Composition for ophthalmic administration.US 20140206708 A1 |
|
|